A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab-Treated non-small Cell Lung Cancer Patients

Netterberg, I; Li, CC; Molinero, L; Budha, N; Sukumaran, S; Stroh, M; Jonsson, EN; Friberg, LE

Li, CC (reprint author), Genentech Inc, Dept Clin Pharmacol, San Francisco, CA 94080 USA.

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019; 105 (2): 486

Abstract

To assess circulating biomarkers as predictors of antitumor response to atezolizumab (anti-programmed death-ligand 1 (PD-L1), Tecentriq) serum pharmac......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索